Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future

25 Mar 2021

Abstract excerpt

The adoptive transfer of natural killer (NK) cells is an emerging therapy in the field of immuno-oncology. In the last 3 decades, NK cells have been utilized to harness the anti-tumor immune response in a wide range of malignancies, most notably with early evidence of efficacy in hematologic malignancies. NK cells are dysfunctional in patients with hematologic malignancies, and their number and function are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Hematopoietic Stem Cell Transplantation
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33766099
DOI: 10.1186/s13287-021-02277-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the futurePMID 33766099Read ↗

Advantages and clinical applications of natural killer cells in cancer immunotherapy.Semantic proximity Read ↗

Adoptive NK cell therapy in AML: progress and challengesSemantic proximity Read ↗

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic StrategiesSemantic proximity Read ↗

Natural killer cell‐based immunotherapy in cancer: current insights and future prospectsSemantic proximity Read ↗

The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia.Semantic proximity Read ↗

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challengesSemantic proximity Read ↗

Natural Born Killers: NK Cells in Cancer TherapySemantic proximity Read ↗

High-Risk Leukemia: Past, Present, and Future Role of NK CellsSemantic proximity Read ↗

CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedsideSemantic proximity Read ↗

Dark NKnight rising: a current perspective on NK cell and CAR-NK cell therapySemantic proximity Read ↗

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies.Semantic proximity Read ↗

Natural killer cell-based therapies in neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.